Xylem (NYSE: XYL) reported Q2 EPS of $1.26, $0.11 better than the analyst estimate of $1.15. Revenue for the quarter came in at $2.3 billion versus the consensus estimate of $2.21 billion.

GUIDANCE:

Xylem sees FY2025 EPS of $4.70-$4.85, versus the consensus of $4.65. Xylem sees FY2025 revenue of $8.9-9 billion, versus the consensus of $8.77 billion.

For earnings history and earnings-related data on Xylem (XYL) click here.